Synthesis of non-competitive inhibitors of Sphingomyelinases with significant activity

Bioorganic & Medicinal Chemistry Letters
2003.0

Abstract

A series of short-chain analogues of N-palmitoylsphingosine-1-phosphate, modified by replacement of the phosphate and the long alkenyl side chain with hydrolytically stable difluoromethylene phosphonate and phenyl, respectively, were prepared to study the structure-activity relationship for inhibition of sphingomyelinase. The study revealed that inhibition is highly dependent upon the stereochemistry of the asymmetric centers of the acylamino moiety, and resulted in identification of a non-competitive inhibitor with the same level of inhibitory activity of schyphostatin, the most potent of the few known small molecular inhibitors of sphingomyelinase.

Knowledge Graph

Similar Paper

Synthesis of non-competitive inhibitors of Sphingomyelinases with significant activity
Bioorganic & Medicinal Chemistry Letters 2003.0
Synthesis and evaluation of a difluoromethylene analogue of sphingomyelin as an inhibitor of sphingomyelinase
Bioorganic & Medicinal Chemistry Letters 2001.0
Sphingomyelin analogues as inhibitors of sphingomyelinase
Bioorganic & Medicinal Chemistry Letters 2003.0
Studies on the inhibition of sphingosine-1-phosphate lyase by stabilized reaction intermediates and stereodefined azido phosphates
European Journal of Medicinal Chemistry 2016.0
Synthesis and evaluation of novel phosphate ester analogs as neutral sphingomyelinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2010.0
Structure-activity relationship of short-chain sphingoid bases as inhibitors of sphingosine kinase
Bioorganic & Medicinal Chemistry Letters 1999.0
Synthesis and Evaluation of Sphingosine Analogues as Inhibitors of Sphingosine Kinases
Journal of Medicinal Chemistry 2009.0
Identification of selective inhibitors of sphingosine kinases 1 and 2 through a structure–activity relationship study of 4-epi-jaspine B
Bioorganic & Medicinal Chemistry 2017.0
Discovery of N-hydroxy-3-alkoxybenzamides as direct acid sphingomyelinase inhibitors using a ligand-based pharmacophore model
European Journal of Medicinal Chemistry 2018.0
Chemical synthesis of D-erythro-sphingosine-1-phosphate, and its inhibitory effect on cell motility
Bioorganic & Medicinal Chemistry Letters 1992.0